SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Nephrology Consultation — Jack London — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJack London
Date of birth1876-01-12
IdentifiersMRN HR-ET010-SYN-TD; SSN (made up) 000-10-4482
Document date1915-08-18
AuthorTeodor Mbatha-Rasmussen, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Reduced kidney function (creatinine 1.98 mg/dL, eGFR 43) with albumin in the urine (240 mg/g) and untreated high blood pressure (158/98) in a 39-year-old writer with severe alcohol use disorder, who has taken naproxen most days for two years. Please confirm the stage and cause, and advise on blood pressure, an SGLT2 inhibitor, medicine for his alcohol use disorder at this kidney function, and pain relief. [S]

Urgency: Within two weeks. [S]

Questions for the consultant:

History of Present Illness

Mr. London, 39, a novelist who writes every morning on his ranch, is seen at the request of Dr. Whitcombe-Ibe two weeks after reduced kidney function, albumin in the urine and high blood pressure were found, together with severe alcohol use disorder. He stopped drinking the day after the intake visit and completed a five-day chlordiazepoxide taper without complications; he has had no alcohol for twelve days. He stopped naproxen and takes acetaminophen. He has taken losartan 50 mg for two weeks without dizziness. He has never passed a stone or had gout, blood in the urine or a rash. He remembers being told years ago that his kidneys were damaged, at an operation for his appendix. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen 500 mg oral tablet twice daily, bought over the counter at full strength and taken most days for about two years for knee and back pain; stopped at intakeOne tablet by mouth twice a day, self-directedOral route1913-08-01 to 1915-08-04stoppedS
Losartan 50 mg oral tablet once dailyOne tablet by mouth every morningOral route1915-08-04 to 1915-09-15completedS
Chlordiazepoxide 25 mg oral capsule, fixed five-day taper for alcohol withdrawal (four capsules on day 1, three on day 2, two on day 3, one on days 4 and 5), dispensed for five days only, with a daily telephone checkUp to one capsule four times a day on day 1, tapering to one a day by day 4; stop after day 5; no alcohol or drivingOral route1915-08-04 to 1915-08-08completedS
Thiamine 100 mg oral tablet once dailyOne tablet by mouth dailyOral route1915-08-04activeS
Acetaminophen 500 mg oral tablet, one or two tablets up to four times a day as needed for pain, no more than 2,000 mg in a day, in place of naproxenOne to two tablets by mouth every six hours as needed; no more than four tablets a dayOral route1915-08-04activeS
Naltrexone 50 mg oral tablet once daily, with a wallet card warning that it blocks opioid pain medicinesOne tablet by mouth every morningOral route1915-08-18activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Tiredness, ankle swelling and high blood pressure (158/98 mmHg) with a raised creatinine (1.98 mg/dL, eGFR 43) and albumin in the urine (240 mg/g), found at intake; a creatinine of 1.7 mg/dL at an insurance examination about fourteen months ago, by his account; chronicity and cause under evaluation with a nephrology consultationresolvedconfirmed R94.4S — Synthetic presenting problem anchored to the documented kidney damage found in 1913; superseded when the consultation staged chronic kidney disease.
Chronic kidney disease, stage G3b A2 (eGFR 42 to 43, urine albumin 240 mg/g), most likely from hypertension with a contribution from two years of daily naproxen; kidneys of normal size, without stones or obstruction; urine sediment bland; synthetic modern diagnosis linked to his documented kidney diseaseactiveconfirmed N18.32S — Synthetic modern diagnosis made at the consultation, anchored to his documented kidney damage and death from uraemia; the cause in the modern episode is synthetic and is not a claim about his real kidneys.
Hypertensive chronic kidney disease, untreated until intakeactiveconfirmed I12.9S — Synthetic modern diagnosis made at the consultation.
Alcohol use disorder, severe (seven DSM-5-TR criteria): a bottle of whisky or more most days for years, a morning drink to steady his hands, failed attempts to cut down, and drinking despite knowing it harms his health; AUDIT 27; PEth 410 ng/mLactiveconfirmed F10.20S — Synthetic modern diagnosis anchored to his own published account of heavy drinking; the criteria, scores and amounts are synthetic and are not a claim about his real drinking.
Alcohol-associated fatty liver without advanced fibrosis (liver stiffness 7.2 kPa; steatosis on ultrasound); FIB-4 2.28 at intakeactiveconfirmed K70.0S — Synthetic finding of the ultrasound and elastography at the consultation; not a claim about his real liver.
Daily self-directed naproxen for knee and back pain for about two years, stopped at intake; acetaminophen in its placeresolvedconfirmed Z79.1S — Synthetic medication history; the joint pain is anchored to the documented rheumatism of 1914, which is not given a diagnosis.
Cigarette smoking, about ten a day; not ready to stop while he stops drinkingactiveconfirmed F17.210S — Synthetic tobacco use; a physician-author's suggestion of heavy tobacco use is recorded only as a retrospective claim.

Physical Exam

Vital signs recorded on 1915-08-18; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 146/92, pulse 84; weight 83.6 kg
CardiovascularRegular rhythm; no murmur or bruit; trace ankle edema
SkinNo rash, purpura or tophi
NeurologicalNo tremor

Results

DateMeasureValueUnitReference rangeFlagProvenance
1915-08-18Potassium [Moles/volume] in Serum or Plasma4.9mmol/L3.5-5.1 mmol/LNormalS
1915-08-18Creatinine [Mass/volume] in Serum or Plasma2.04mg/dL0.74-1.35 mg/dLHighS
1915-08-18Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1910)/1.73 sq M42mL/min/{1.73_m2}45 to 59 is G3a; 30 to 44 is G3bLowS
1915-08-18Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma49U/L10-40 U/LHighS
1915-08-18Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma36U/L9-46 U/LNormalS
1915-08-18Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma141U/L8-61 U/LHighS

Assessment

Data reviewed: Dr. Whitcombe-Ibe's intake note and results: creatinine 1.98 mg/dL, eGFR 43, urine albumin-to-creatinine ratio 240 mg/g, uric acid 8.4 mg/dL, PTH 74 pg/mL, hemoglobin 13.6 g/dL, AST 68, ALT 41, GGT 186 U/L, FIB-4 2.28, PEth 410 ng/mL, HbA1c 5.4%. Urinalysis: 2+ protein, no blood, no casts or crystals. Insurance examination report: creatinine 1.7 mg/dL about fourteen months ago. Today: potassium 4.9 mmol/L, creatinine 2.04 mg/dL (eGFR 42), AST 49, ALT 36, GGT 141 U/L. Ultrasound this morning: kidneys 10.8 and 11.0 cm, echogenic, no stones, hydronephrosis or cysts; fatty liver; normal spleen. Elastography: liver stiffness 7.2 kPa, controlled attenuation parameter 312 dB/m. Kidney failure risk equation: five-year risk about 5 percent, two-year about 1.5 percent. Estimated creatinine clearance (Cockcroft-Gault) about 58 mL/min. [S]

Plan of Treatment